Ali Sultan-Qurraie, MD
Neurology · Renton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Valley Medical Group-Renton · County of Santa Clara · King County Public Hospital District No 2
Looking this up.
Hospitals listed: Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sultan-Qurraie’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A131959 · Current
Licensed to practise in California · since 2014 · expires 2027-09-30 · Virginia Commonwealth University, Medical College of Virginia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.60405480Physician And Surgeon License · since 2013 · expires 2028-09-16ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Valley Medical CenterRenton, WAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of UW Medicine, which runs 4 hospitalsPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.69 (1.38 to 1.99), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 3.51 (2.89 to 4.13) · 5,445 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.4 (10.8 to 19) · 208 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.441, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.513, Oct 2024 – Sep 2025
See every measure and the patient survey for Valley Medical Center
Behind the star rating — Deaths: 1 better, 4 the same, 2 worse of 7 measures. Safety: 1 better, 4 the same, 1 worse of 6 measures. Readmissions: 2 better, 5 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.69 (1.38 to 1.99) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 3.51 (2.89 to 4.13) · 5,445 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.4 (10.8 to 19) · 208 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.441 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.513 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,237 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 175.11 (128.65 to 221.56) · 92 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 16.2 · 511 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.4 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 506 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,498 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.34) · 6,246 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.13 to 0.51) · 6,227 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (1.2 to 5.2) · 1,469 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.9 (0.27 to 3.53) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (1.17 to 4.12) · 1,452 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.56 (0 to 13.24) · 571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.55 (0 to 7.13) · 497 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 312 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.003 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.869 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 199 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -28.9 · 102 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.1 · 386 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 638 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (2.9 to 6.3) · 208 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 279 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.9 to 15.9) · 2,650 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.3) · 760 cases | No different | Jan 2024 – Dec 2024 |
What patients said (904 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$40,723
Medicare paid this office $40,723 for 80 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 15 | $9,996 | $666 |
| Long return visit (40+ min) | 31 | $3,910 | $115 |
| Return visit (30+ min) | 13 | $907 | $57 |
| Ultrasonic guidance for blood vessel access | 12 | $159 | $11 |
Who their Medicare patients are
80 Original Medicare patients in 2024. Average age 76 · Women 51% · Health risk score 1.13. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 71% · Diabetes 39% · Coronary heart disease 30% · Chronic kidney disease 29% · Heart failure 26% · Atrial fibrillation 26% · Depression 20%.
The office billed $223,119, Medicare allowed $52,454 and paid $40,723; for 203 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 80 | 203 | 76 | 1.13 | $223,119 | $40,723 |
| 2023 | 69 | 137 | 77 | 1.48 | $132,284 | $28,626 |
| 2022 | 65 | 210 | 76 | 1.94 | $236,572 | $40,641 |
| 2021 | 72 | 210 | 75 | 1.52 | $221,979 | $29,194 |
| 2020 | 63 | 168 | 75 | 1.79 | $176,906 | $29,272 |
| 2019 | 91 | 241 | 74 | 1.68 | $260,851 | $42,570 |
| 2018 | 59 | 93 | 70 | 2.11 | $43,710 | $13,114 |
| 2017 | 78 | 152 | 73 | 2.06 | $72,692 | $12,966 |
| 2016 | 69 | 147 | 72 | 1.86 | $60,629 | $11,857 |
| 2015 | 262 | 1,013 | 73 | 1.71 | $180,145 | $55,157 |
| 2014 | 85 | 144 | 75 | 1.38 | $45,448 | $15,530 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 16 | $11,063 | $691 |
| Return visit (30+ min) | 20 | $1,696 | $77 |
| Long return visit (40+ min) | 12 | $1,453 | $121 |
2022: 5 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 16 | $10,557 | $621 |
| Critical care, first 30-74 minutes | 12 | $5,668 | $183 |
| Return visit (30+ min) | 21 | $1,591 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,128 | $81 |
| Ultrasonic guidance for blood vessel access | 11 | $135 | $10 |
2021: 3 services
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 11 | $4,043 | $311 |
| Return visit (30+ min) | 18 | $1,718 | $78 |
| Short return visit (20+ min) | 12 | $813 | $58 |
2020: 5 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 11 | $7,945 | $722 |
| Critical care, first 30-74 minutes | 12 | $3,805 | $190 |
| Long return visit (40+ min) | 14 | $1,348 | $90 |
| Return visit (30+ min) | 17 | $1,154 | $61 |
| Ultrasonic guidance for blood vessel access | 11 | $149 | $12 |
2019: 9 services
| Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | 13 | $9,285 | $714 |
| Critical care, first 30-74 minutes | 23 | $9,243 | $189 |
| Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | 14 | $5,903 | $394 |
| New patient visit (60+ min) | 17 | $2,337 | $137 |
| Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | 11 | $1,838 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,503 | $84 |
| Return visit (30+ min) | 19 | $1,484 | $67 |
| Long return visit (40+ min) | 13 | $1,141 | $88 |
| Ultrasonic guidance for blood vessel access | 11 | $148 | $12 |
2018: 3 services
| Critical care, first 30-74 minutes | 17 | $6,147 | $181 |
| Return visit (30+ min) | 19 | $1,605 | $80 |
| Short return visit (20+ min) | 13 | $810 | $54 |
2017: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $4,951 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,252 | $155 |
| Hospital discharge day management, 30 minutes or less | 13 | $723 | $56 |
2016: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $6,682 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,127 | $152 |
| Hospital discharge day management, 30 minutes or less | 11 | $554 | $50 |
2015: 10 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,073 | $162 |
| New patient visit (60+ min) | 50 | $7,733 | $155 |
| Return visit (30+ min) | 76 | $7,488 | $78 |
| Short return visit (20+ min) | 83 | $6,221 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $6,035 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $3,712 | $59 |
| Long return visit (40+ min) | 32 | $3,695 | $112 |
| New patient visit (45+ min) | 26 | $2,985 | $115 |
| Measurement of brain wave activity (eeg), awake and drowsy | 27 | $1,276 | $47 |
| Hospital discharge day management, 30 minutes or less | 16 | $897 | $56 |
2014: 5 services
| New patient visit (60+ min) | 38 | $6,209 | $163 |
| New patient visit (45+ min) | 14 | $1,853 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,798 | $163 |
| Return visit (30+ min) | 18 | $1,669 | $88 |
| Long return visit (40+ min) | 11 | $1,312 | $109 |
Drugs they prescribed that Part D paid
$517
Pharmacies billed $517 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 16) in 2024. Too few prescriptions to compare fairly with other clinicians.
15 generic and fewer than 11 brand-name prescriptions · $517 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clopidogrel | 13 | $53 | $4 |
Year by year
| 2024 | 16 | None | 0% (0) | None | $517 |
| 2023 | 29 | None | 0% (0) | 0% | $436 |
| 2022 | 26 | None | 0% (0) | None | $5,753 |
| 2021 | 17 | None | 0% (0) | None | $3,482 |
| 2020 | 26 | None | 0% (0) | 0% | $570 |
| 2019 | 30 | 15 | 0% (0) | None | $1,087 |
| 2018 | 13 | None | 0% (0) | 0% | $81 |
| 2017 | 46 | 18 | 0% (0) | None | $628 |
| 2016 | 80 | 26 | None | None | $2,203 |
| 2015 | 279 | 60 | 0% (0) | 7% | $11,915 |
| 2014 | 37 | 13 | 0% (0) | None | $4,512 |
| 2013 | 39 | 11 | 0% (0) | None | $2,440 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Clopidogrel | 15 | $233 | $16 |
2021: 1 drug
| Clopidogrel | 11 | $86 | $8 |
2020: 1 drug
| Clopidogrel | 15 | $191 | $13 |
2019: 1 drug
| Clopidogrel | 18 | $306 | $17 |
2018: 1 drug
| Clopidogrel | 12 | $78 | $7 |
2017: 1 drug
| Clopidogrel | 13 | $126 | $10 |
2016: 1 drug
| Clopidogrel | 13 | $68 | $5 |
2015: 6 drugs
| Gabapentin | 76 | $1,172 | $15 |
| Nortriptyline | 32 | $405 | $13 |
| Donepezil | 41 | $358 | $9 |
| Quetiapine | 15 | $111 | $7 |
| Topiramate | 14 | $110 | $8 |
| Clopidogrel | 12 | $80 | $7 |
Money from drug and device companies
$11,217 in 2025
| 2025 | 10 | 87 | $3,000 | $11,217 |
| 2024 | 7 | 87 | $1,500 | $10,322 |
| 2023 | 7 | 46 | None | $3,599 |
| 2022 | 9 | 32 | None | $1,536 |
| 2021 | 9 | 28 | $2,500 | $5,145 |
| 2020 | 2 | 11 | None | $269 |
| 2019 | 6 | 19 | None | $2,193 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Supera | $4,613 | 6 payments
|
| Penumbra | Smart Coil | $3,477 | 33 payments
|
| MicroVention | Web Aneurysm Embolization System | $2,001 | 24 payments
|
| DePuy Synthes Sales | Cerepak Uniform | $463 | 12 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $207 | 1 payment
|
| Medtronic | Pipeline | $169 | 2 payments
|
See all 86 published payments
| Stryker | Meals · 2025-12-17 | Surpass Evolve | $54 |
| Penumbra | Meals · 2025-12-15 | Smart Coil | $9 |
| DePuy Synthes Sales | Meals · 2025-12-14 | Trufill | $4 |
| Penumbra | Meals · 2025-12-11 | Smart Coil | $68 |
| Penumbra | Travel · 2025-12-08 | Indigo System | $228 |
| Penumbra | Meals · 2025-12-07 | Penumbra System | $173 |
| Penumbra | Travel · 2025-12-06 | Smart Coil | $969 |
| Penumbra | Meals · 2025-12-06 | Smart Coil | $369 |
| Penumbra | Travel · 2025-12-06 | Smart Coil | $69 |
| Penumbra | Meals · 2025-12-05 | Penumbra System | $83 |
| Penumbra | Meals · 2025-12-05 | Penumbra System | $18 |
| Penumbra | Travel · 2025-12-05 | Smart Coil | $288 |
| DePuy Synthes Sales | Meals · 2025-12-01 | Trufill | $14 |
| MicroVention | Meals · 2025-11-12 | Web Aneurysm Embolization System | $199 |
| Penumbra | Meals · 2025-11-07 | Penumbra System | $88 |
| DePuy Synthes Sales | Meals · 2025-11-06 | Trufill | $23 |
| MicroVention | Meals · 2025-11-06 | Chaperon Guiding Catheter | $29 |
| Cordis US | Meals · 2025-11-06 | Mynx Control Venous | $57 |
| DePuy Synthes Sales | Meals · 2025-10-13 | Cerepak Uniform | $41 |
| Penumbra | Meals · 2025-10-09 | Benchmark | $64 |
| Medtronic | Meals · 2025-10-06 | Pipeline | $9 |
| Penumbra | Meals · 2025-09-29 | Red 72 | $11 |
| MicroVention | Meals · 2025-09-23 | Web Aneurysm Embolization System | $13 |
| MicroVention | Meals · 2025-09-18 | Chaperon Guiding Catheter | $44 |
| Qapel Medical | Meals · 2025-09-15 | None | $14 |
| DePuy Synthes Sales | Meals · 2025-09-12 | Embotrap | $32 |
| MicroVention | Meals · 2025-09-10 | Chaperon Guiding Catheter | $21 |
| DePuy Synthes Sales | Meals · 2025-09-08 | Trufill | $4 |
| Penumbra | Meals · 2025-09-08 | Penumbra Coil 400 | $9 |
| Stryker | Meals · 2025-09-05 | Broadway 8 | $46 |
| Penumbra | Meals · 2025-08-29 | Benchmark | $42 |
| MicroVention | Meals · 2025-08-29 | Bobby | $9 |
| Balt USA | Meals · 2025-08-28 | Ballast 088 Long Sheath | $31 |
| DePuy Synthes Sales | Meals · 2025-08-25 | Trufill | $106 |
| Cordis US | Meals · 2025-08-25 | Mynx Control | $17 |
| Abbott Laboratories | Meals · 2025-08-18 | Emboshield Nav6 | $8 |
| Penumbra | Meals · 2025-08-04 | Penumbra System | $12 |
| MicroVention | Meals · 2025-07-31 | Chaperon Guiding Catheter | $54 |
| Penumbra | Meals · 2025-07-28 | Benchmark | $40 |
| Penumbra | Meals · 2025-07-23 | Penumbra System | $7 |
| Penumbra | Meals · 2025-07-11 | Penumbra System | $77 |
| DePuy Synthes Sales | Meals · 2025-07-05 | Trufill | $35 |
| MicroVention | Meals · 2025-07-04 | Stent | $32 |
| Stryker | Meals · 2025-06-27 | Broadway 8 | $44 |
| Penumbra | Meals · 2025-06-26 | Penumbra System | $59 |
| MicroVention | Travel · 2025-06-24 | Web Aneurysm Embolization System | $203 |
| MicroVention | Travel · 2025-06-19 | Web Aneurysm Embolization System | $226 |
| MicroVention | Travel · 2025-06-19 | Web Aneurysm Embolization System | $226 |
| MicroVention | Travel · 2025-06-19 | Web Aneurysm Embolization System | $194 |
| MicroVention | Travel · 2025-06-19 | Web Aneurysm Embolization System | $35 |
| MicroVention | Meals · 2025-06-19 | Stent | $29 |
| MicroVention | Travel · 2025-06-18 | Web Aneurysm Embolization System | $35 |
| MicroVention | Travel · 2025-06-18 | Web Aneurysm Embolization System | $318 |
| Stryker | Meals · 2025-06-13 | Neuroform Atlas | $23 |
| MicroVention | Meals · 2025-06-12 | None | $87 |
| Penumbra | Meals · 2025-06-09 | Penumbra System | $7 |
| Penumbra | Meals · 2025-06-06 | Smart Coil | $43 |
| Penumbra | Meals · 2025-06-06 | Smart Coil | $11 |
| Abbott Laboratories | Consulting · 2025-06-06 | Supera | $3,000 |
| Abbott Laboratories | Travel · 2025-06-06 | Supera | $76 |
| MicroVention | Meals · 2025-05-30 | Web Aneurysm Embolization System | $100 |
| MicroVention | Meals · 2025-05-28 | Sofia 6f-131cm Str | $65 |
| Shockwave Medical | Meals · 2025-05-22 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $207 |
| Penumbra | Meals · 2025-05-22 | Benchmark | $54 |
| MicroVention | Meals · 2025-05-01 | Headway Advanced Soft | $6 |
| Penumbra | Meals · 2025-04-29 | Smart Coil | $160 |
| Medtronic | Meals · 2025-04-16 | Pipeline | $160 |
| MicroVention | Meals · 2025-04-15 | Headway Advanced Soft | $4 |
| MicroVention | Meals · 2025-04-15 | Headway Advanced Soft | $7 |
| Penumbra | Meals · 2025-04-08 | Penumbra System | $55 |
| Abbott Laboratories | Travel · 2025-04-05 | Supera | $1,174 |
| Abbott Laboratories | Travel · 2025-04-05 | Supera | $346 |
| Abbott Laboratories | Travel · 2025-04-05 | Supera | $9 |
| DePuy Synthes Sales | Meals · 2025-03-20 | Cerepak Uniform | $141 |
| MicroVention | Meals · 2025-02-28 | Stent | $49 |
| DePuy Synthes Sales | Meals · 2025-02-26 | Cerepak Uniform | $28 |
| MicroVention | Meals · 2025-02-17 | Stent | $19 |
| Penumbra | Meals · 2025-02-06 | Artemis | $131 |
| Penumbra | Meals · 2025-02-05 | Penumbra Coil 400 | $38 |
| Penumbra | Meals · 2025-02-04 | Penumbra System | $166 |
| Penumbra | Meals · 2025-02-04 | Penumbra Coil 400 | $7 |
| Penumbra | Meals · 2025-02-04 | Benchmark | $11 |
| Penumbra | Meals · 2025-01-14 | Artemis | $77 |
| DePuy Synthes Sales | Meals · 2025-01-10 | Embotrap | $12 |
| DePuy Synthes Sales | Meals · 2025-01-08 | Embotrap | $23 |
| Penumbra | Meals · 2025-01-07 | Benchmark | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $10,322
| Penumbra | Penumbra System | $4,993 | 42 payments
|
| Abbott Laboratories | Xact | $1,991 | 5 payments
|
| Medtronic | Pipeline | $1,644 | 11 payments
|
| MicroVention | Web Aneurysm Embolization System | $876 | 16 payments
|
| Imperative Care | Zoom 88-T Large Distal Platform | $561 | 5 payments
|
| DePuy Synthes Sales | Cerepak Uniform | $230 | 7 payments
|
| Stryker | Target | $27 | 1 payment
|
2023: $3,599
| MicroVention | Web Aneurysm Embolization System | $1,638 | 8 payments
|
| Penumbra | Smart Coil | $1,094 | 23 payments
|
| DePuy Synthes Sales | Emboguard | $346 | 7 payments
|
| Abbott Laboratories | Xact | $270 | 3 payments
|
| Medtronic | Solitaire X | $195 | 3 payments
|
| Stryker | Target | $40 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $15 | 1 payment
|
2022: $1,536
| DePuy Synthes Sales | Embotrap | $684 | 12 payments
|
| Viz.ai | Viz.Ai Lvo | $336 | 2 payments
|
| Penumbra | Penumbra Coil 400 | $205 | 11 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $118 | 1 payment
|
| Stryker | Surpass Evolve | $51 | 1 payment
|
| Imperative Care | Zoom Reperfusion Catheter | $46 | 1 payment
|
| MicroVention | Sofia 6f-131cm Str | $33 | 1 payment
|
| Abbott Laboratories | Xact | $32 | 2 payments
|
| Medtronic | Pipeline | $31 | 1 payment
|
2021: $5,145
| Abbott Laboratories | Xact Carotid Stent System | $2,665 | 3 payments
|
| Medical Device Business Services | Pulsar Vascular Pulserider Aneurysm Neck Reconstruction Device | $1,492 | 6 payments
|
| DePuy Synthes Sales | Embotrap | $256 | 2 payments
|
| Penumbra | Smart Coil | $175 | 10 payments
|
| MicroVention | Web Aneurysm Embolization System | $150 | 1 payment
|
| Imperative Care | Tracstarlargedistalplatform | $142 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $120 | 1 payment
|
| Medtronic | Pipeline | $90 | 3 payments
|
| Stryker | Trevo | $54 | 1 payment
|
2020: $269
| Medtronic USA | Solitaire | $185 | 5 payments
|
| Penumbra | Jet 7 | $84 | 6 payments
|
2019: $2,193
| Stryker | Trevo | $1,482 | 10 payments
|
| Medtronic USA | Solitaire | $249 | 2 payments
|
| Penumbra | Penumbra System | $203 | 4 payments
|
| Teva Pharmaceuticals USA | Ajovy | $125 | 1 payment
|
| Amgen | Aimovig | $111 | 1 payment
|
| DePuy Synthes Sales | Pulserider | $23 | 1 payment
|
Professional record
- NPI
- 1114156940
- Licence
- CA A131959, OH 35133254, WA MD60405480, WI 64358California A131959: Current · expires 2027-09-30Washington MD.MD.60405480: Active
- Group
- Valley Medical Group-Renton · County of Santa Clara · King County Public Hospital District No 2
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 2019320, WI 1114156940
- Taxonomy
- Federal specialty code 2084V0102X (2084V0102X); Federal specialty code 2084A2900X (2084A2900X); Neurology (2084N0400X)
- Mailing address
- 3600 Lind Ave Sw, Suite 100 Attn Credentialing, Renton, WA, 98057
- NPI first listed
- 2009-07-14
- NPI last updated
- 2023-07-18
- NPI record certified
- 2023-07-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2213 Cherry St, Toledo, OH, 43608